Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes

Journal of Lipid Research

Volumn 49, Issue 12, 2008, Pages 2590-2604

  Gannon, Anne Marie M ^a   Kinsella, B Therese ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Platelet; Promoter; Prostanoid; Transcription

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PROMOTER 1; THROMBOXANE A2 RECEPTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR SP1; TUMOR PROMOTER; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; SITE DIRECTED MUTAGENESIS; STEM CELL; THROMBOCYTE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GATA1 TRANSCRIPTION FACTOR; HUMANS; MEGAKARYOCYTES; NF-E2 TRANSCRIPTION FACTOR; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 59649116172     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800256-JLR200     Document Type: Article

References (58)

1. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79: 1193-1226.
2. Fitzgerald, D. J., L. Roy, F. Catella, and G. A. FitzGerald. 1986. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315: 983-989.
3. Hirsh, P. D., L. D. Hillis, W. B. Campbell, B. G. Firth, and J. T. Willerson. 1981. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N. Engl. J. Med. 304: 685-691.
4. Fitzgerald, D. J., W. Rocki, R. Murray, G. Mayo, and G. A. FitzGerald. 1990. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet. 335: 751-754.
5. Raychowdhury, M. K., M. Yukawa, L. J. Collins, S. H. McGrail, K. C. Kent, and J. A. Ware. 1994. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J. Biol. Chem. 269: 19256-19261.
6. Hirata, M., Y. Hayashi, F. Ushikubi, Y. Yokota, R. Kageyama, S. Nakanishi, and S. Narumiya. 1991. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature. 349: 617-620.
7. Walsh, M., J. F. Foley, and B. T. Kinsella. 2000. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor: effector coupling. Biochim. Biophys. Acta. 1496: 164-182.
8. Hirata, T., A. Kakizuka, F. Ushikubi, I. Fuse, M. Okuma, and S. Narumiya. 1994. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J. Clin. Invest. 94: 1662-1667.
9. Vezza, R., A. Habib, and G. A. FitzGerald. 1999. Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J. Biol. Chem. 274: 12774-12779.
10. Kelley-Hickie, L. P., and B. T. Kinsella. 2006. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor. Biochim. Biophys. Acta. 1761: 1114-1131.
11. Parent, J. L., P. Labrecque, M. Driss Rochdi, and J. L. Benovic. 2001. Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: identification of a distinct motif for tonic internalization. J. Biol. Chem. 276: 7079-7085.
12. Reid, H. M., and B. T. Kinsella. 2003. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin. J. Biol. Chem. 278: 51190-51202.
13. Walsh, M. T., J. F. Foley, and B. T. Kinsella. 2000. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization. J. Biol. Chem. 275: 20412-20423.
14. Parent, J. L., P. Labrecque, M. J. Orsini, and J. L. Benovic. 1999. Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced cooh terminus in agonist-promoted receptor internalization. J. Biol. Chem. 274: 8941-8948.
15. Miggin, S. M., and B. T. Kinsella. 1998. Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms. Biochim. Biophys. Acta. 1425: 543-559.
16. Habib, A., G. A. FitzGerald, and J. Maclouf. 1999. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J. Biol. Chem. 274: 2645-2651.
17. Nusing, R. M., M. Hirata, A. Kakizuka, T. Eki, K. Ozawa, and S. Narumiya. 1993. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J. Biol. Chem. 268: 25253-25259.
18. Coyle, A. T., S. M. Miggin, and B. T. Kinsella. 2002. Characterization of the 5′ untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms. Eur. J. Biochem. 269: 4058-4073.
19. Coyle, A. T., and B. T. Kinsella. 2005. Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity. FEBS J. 272: 1036-1053.
20. D'Angelo, D. D., M. G. Davis, W. A. Houser, J. J. Eubank, M. E. Ritchie, and G. W. Dorn II. 1995. Characterization of 5′ end of human thromboxane receptor gene. Organizational analysis and mapping of protein kinase C-responsive elements regulating expression in platelets. Circ. Res. 77: 466-474.
21. Coyle, A. T., M. B. O'Keeffe, and B. T. Kinsella. 2005. 15-Deoxy delta 12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. FEBS J. 272: 4754-4773.
22. Saffak, T., and R. M. Nusing. 2002. The 5′ region of the human thromboxane A(2) receptor gene. Prostaglandins Leukot. Essent. Fatty Acids. 67: 25-31.
23. Hoffmann, E., J. Ashouri, S. Wolter, A. Doerrie, O. Dittrich-Breiholz, H. Schneider, E. F. Wagner, J. Troppmair, N. Mackman, and M. Kracht. 2008. Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J. Biol. Chem. 283: 12120-12128.
24. Kooren, J., R. J. Palstra, P. Klous, E. Splinter, M. von Lindern, F. Grosveld, and W. de Laat. 2007. Beta-globin active chromatin Hub formation in differentiating erythroid cells and in p45 NF-E2 knockout mice. J. Biol. Chem. 282: 16544-16552.
25. Murakami, Y., S. Yamagoe, K. Noguchi, Y. Takebe, N. Takahashi, Y. Uehara, and H. Fukazawa. 2006. Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpes virus through interaction with Daxx. J. Biol. Chem. 281: 28113-28121.
26. Sawado, T., K. Igarashi, and M. Groudine. 2001. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter. Proc. Natl. Acad. Sci. USA. 98: 10226-10231.
27. Sinha-Datta, U., I. Horikawa, E. Michishita, A. Datta, J. C. Sigler-Nicot, M. Brown, M. Kazanji, J. C. Barrett, and C. Nicot. 2004. Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood. 104: 2523-2531.
28. Sobue, S., K. Hagiwara, Y. Banno, K. Tamiya-Koizumi, M. Suzuki, A. Takagi, T. Kojima, H. Asano, Y. Nozawa, and T. Murate. 2005. Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. J. Neurochem. 95: 940-949.
29. Sohn, R. H., C. B. Deming, D. C. Johns, H. C. Champion, C. Bian, K. Gardner, and J. J. Rade. 2005. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 105: 3910-3917.
30. Zhang, F., T. E. Ahlborn, C. Li, F. B. Kraemer, and J. Liu. 2002. Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter. J. Lipid Res. 43: 1477-1485.
31. Thiel, G., S. Schoch, and D. Petersohn. 1994. Regulation of synapsin I gene expression by the zinc finger transcription factor zif268/egr-1. J. Biol. Chem. 269: 15294-15301.
32. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23: 4878-4884.
33. Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3: 229-254.
34. Koch, C. M., R. M. Andrews, P. Flicek, S. C. Dillon, U. Karaoz, G. K. Clelland, S. Wilcox, D. M. Beare, J. C. Fowler, P. Couttet, et al. 2007. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 17: 691-707.
35. Coyle, A. T., and B. T. Kinsella. 2006. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. Biochem. Pharmacol. 71: 1308-1323.
36. Pugh, B. F., and R. Tjian. 1991. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5: 1935-1945.
37. Pascal, E., and R. Tjian. 1991. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5: 1646-1656.
38. Huang, R. P., Y. Fan, Z. Ni, D. Mercola, and E. D. Adamson. 1997. Reciprocal modulation between Sp1 and Egr-1. J. Cell. Biochem. 66: 489-499.
39. Andrews, N. C., K. J. Kotkow, P. A. Ney, H. Erdjument-Bromage, P. Tempst, and S. H. Orkin. 1993. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc. Natl. Acad. Sci. USA. 90: 11488-11492.
40. Mignotte, V., L. Wall, E. deBoer, F. Grosveld, and P. H. Romeo. 1989. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res. 17: 37-54.
41. Kotkow, K. J., and S. H. Orkin. 1995. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15: 4640-4647.
42. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. Saris, and S. H. Orkin. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 81: 695-704.
43. Deveaux, S., S. Cohen-Kaminsky, R. A. Shivdasani, N. C. Andrews, A. Filipe, I. Kuzniak, S. H. Orkin, P. H. Romeo, and V. Mignotte. 1997. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J. 16: 5654-5661.
44. Ikeda, Y., A. Sugawara, Y. Taniyama, A. Uruno, K. Igarashi, S. Arima, S. Ito, and K. Takeuchi. 2000. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2. J. Biol. Chem. 275: 33142-33150.
45. Zhang, L., H. Xiao, R. A. Schultz, and R. F. Shen. 1997. Genomic organization, chromosomal localization, and expression of the murine thromboxane synthase gene. Genomics. 45: 519-528.
46. Nichols, K. E., J. D. Crispino, M. Poncz, J. G. White, S. H. Orkin, J. M. Maris, and M. J. Weiss. 2000. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet. 24: 266-270.
47. Harigae, H. 2006. GATA transcription factors and hematological diseases. Tohoku J. Exp. Med. 210: 1-9.
48. Patient, R. K., and J. D. McGhee. 2002. The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 12: 416-422.
49. Szalai, G., A. C. LaRue, and D. K. Watson. 2006. Molecular mechanisms of megakaryopoiesis. Cell. Mol. Life Sci. 63: 2460-2476.
50. Shivdasani, R. A., Y. Fujiwara, M. A. McDevitt, and S. H. Orkin. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16: 3965-3973.
51. Oikawa, T., and T. Yamada. 2003. Molecular biology of the Ets family of transcription factors. Gene. 303: 11-34.
52. Lulli, V., P. Romania, O. Morsilli, M. Gabbianelli, A. Pagliuca, S. Mazzeo, U. Testa, C. Peschle, and G. Marziali. 2006. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation. Cell Death Differ. 13: 1064-1074.
53. Jackers, P., G. Szalai, O.Moussa, and D. K.Watson. 2004. Ets-dependent regulation of target gene expression during megakaryopoiesis. J. Biol. Chem. 279: 52183-52190.
54. Minami, T., K. Tachibana, T. Imanishi, and T. Doi. 1998. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression. Eur. J. Biochem. 258: 879-889.
55. Deveaux, S., A. Filipe, V. Lemarchandel, J. Ghysdael, P. H. Romeo, and V. Mignotte. 1996. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood. 87: 4678-4685.
56. Wang, X., J. D. Crispino, D. L. Letting, M. Nakazawa, M. Poncz, and G. A. Blobel. 2002. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 21: 5225-5234.
57. Goodwin, A. J., J. M. McInerney, M. A. Glander, O. Pomerantz, and C. H. Lowrey. 2001. In vivo formation of a human beta-globin locus control region core element requires binding sites for multiple factors including GATA-1, NF-E2, erythroid Kruppel-like factor, and Sp1. J. Biol. Chem. 276: 26883-26892.
58. Block, K. L., Y. Shou, and M. Poncz. 1996. An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood. 88: 2071-2080.